Defunct Company
Total Trials
10
As Lead Sponsor
6
As Collaborator
4
Total Enrollment
312
NCT02864966
A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects
Phase: N/A
Role: Collaborator
Start: May 31, 2016
Completion: May 31, 2016
NCT03924154
A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 1, 2019
Completion: Feb 24, 2020
NCT04712669
A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)
Start: Mar 15, 2021
Completion: Aug 28, 2023
NCT05006118
Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl
Phase: Phase 1
Start: Sep 23, 2021
Completion: Oct 6, 2021
NCT05065359
Multiple-Ascending Dose in Japanese Patients Bridging Study
Start: Oct 1, 2021
Completion: Mar 30, 2022
NCT05684640
A Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and Safety
Start: Sep 29, 2022
Completion: Jan 17, 2023
NCT05933447
Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart
Start: May 12, 2023
Completion: Jul 28, 2023